Are beta‐blockers on the therapeutic horizon for ovarian cancer treatment?

Widely used medications for other disease processes, such as beta‐blockers used for the management of hypertension, may provide therapeutic potential in patients with cancer, perhaps by altering the tumor microenvironment. The article by Watkins et al in the current issue performed a comprehensive r...

Full description

Saved in:
Bibliographic Details
Published inCancer Vol. 121; no. 19; pp. 3380 - 3383
Main Authors Bunch, Kristen P., Annunziata, Christina M.
Format Journal Article
LanguageEnglish
Published United States 01.10.2015
Subjects
Adrenergic beta-Antagonists - therapeutic use
Female
Humans
Ovarian Neoplasms - drug therapy
Online AccessGet full text

Cover

More Information
Summary:Widely used medications for other disease processes, such as beta‐blockers used for the management of hypertension, may provide therapeutic potential in patients with cancer, perhaps by altering the tumor microenvironment. The article by Watkins et al in the current issue performed a comprehensive review of beta‐blocker use in women with ovarian cancer, and identified nonselective beta‐blockers associated with longer overall survival.
Bibliography:See referenced original article on pages
3444–51
this issue.
SourceType-Other Sources-1
content type line 63
ObjectType-Editorial-2
ObjectType-Commentary-1
ISSN:0008-543X
1097-0142
DOI:10.1002/cncr.29394